Home LiteratureArticle Details
PMID: 16135843 Published · ppublish English Journal Article

Treating cancer by targeting a weakness.

The New England journal of medicine ·Vol. 353 ·No. 9 ·2005-09-01 ·Pages 949-50

Brody LC

Abstract

暂无摘要

MeSH Terms
Animals Antineoplastic Agents/pharmacology,therapeutic use Cell Survival/drug effects DNA Damage DNA Repair Genes, BRCA1 Genes, BRCA2 Mice Neoplasms/drug therapy,genetics Poly (ADP-Ribose) Polymerase-1 Poly(ADP-ribose) Polymerase Inhibitors Xenograft Model Antitumor Assays
Chemicals
Antineoplastic Agents Poly(ADP-ribose) Polymerase Inhibitors Parp1 protein, mouse Poly (ADP-Ribose) Polymerase-1
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Brody Lawrence C
Genome Technology Branch of the National Human Genome Research Institute, National Institutes of Health, Bethesda, Md, USA.
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
DOI
10.1056/NEJMcibr052331
Published
2005-09-01
Pages
949-50
Language
English
Region
United States
NLM ID
0255562
Subset
IM
External Links
PubMed source DOI: 10.1056/NEJMcibr052331 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2